The Journal of Clinical Endocrinology & Metabolism · 1998 · 10 citations · 12 references
MedicineEndocrinologyGeneticsEndocrine GeneticsHuman GeneticsMedical GeneticsBone Metabolism DisordersDiabetes MellitusDisorders Of Calcium MetabolismGenetic DisordersInherited Endocrine SyndromesParathyroid DisordersAdenylate Cyclase SignalingAdenylyl Cyclase RegulationAdenylyl Cyclase SignalingAlbright Hereditary OsteodystrophyCongenital Metabolic Endocrinopathies
We report a sporadic case of Albright's hereditary osteodystrophy (AHO)-like syndrome with several endocrinopathies. A 37-yr-old woman had an appearance of AHO but did not have renal PTH resistance. Her case was complicated by non-insulin-dependent diabetes mellitus with severe insulin resistance, central diabetes insipidus, and hyposecretion of GH. Most patients with AHO are found in a family of pseudohypoparathyroidism type-Ia and have a heterozygous mutation that inactivates the alpha-subunit of Gs (Gs alpha), the stimulatory regulator of adenylyl cyclase. Some sporadic cases occur in which patients with phenotype similar to AHO have a deletion of chromosome 2q37. However, in this patient, both the Gs alpha gene structure and the biological activity were normal. In addition, chromosome analysis revealed a normal pattern with no visible deletion of chromosome 2q37. Our findings suggest that one or more other factors may be involved in the pathogenesis of AHO-related disease.
12
Rapid GDP release from Gsα in patients with gain and loss of endocrine function
Taroh Iiri, Paul Herzmark, Jon M. Nakamoto et al. · Nature · 1994 · 297 citations
Lee S. Weinstein, Pablo V. Gejman, Eitan Friedman et al. · Proceedings of the National Academy of Sciences · 1990 · 264 citations